Pharmaceutical Licensing Insights

Licensure for Non-Resident Virtual Manufacturers Selling into California

The (Actual) Beginning of the End for PBM Spread Pricing

The Challenge of “Direct-to-Consumer” Pharma and TrumpRx

Puerto Rico Eliminates Special Authorization Licensing Requirement for All Non-Resident Entities

NABP DDA (VAWD) 2025 Pricing Changes Announced

Massachusetts Introduces Non-resident Pharmacy License

Puerto Rico: Virtual Manufacturer and Virtual Distributor License Applications Now Open

Automated Regulatory Updates with LighthouseAI

Puerto Rico Suspends Controlled Substance Applications

FDA Grants Exemptions to Small Dispensers (Pharmacies) for Drug Tracing

Sterile Compounding Solves Semaglutide Access Problems

Kentucky Revisiting Licensing of Non-Registered Pharmacist

The Current State of Xylazine

1856 Regulatory Changes By Regulatory Agencies Since January 1st, 2024

Navigating Puerto Rico's New Licensing Standards for Pharmaceutical Wholesale Distributors

Connecticut Reporting Transparency Updates

Application of AI in the Pharmaceutical Supply Chain

New Mexico Passes Prescription Drug Price Transparency Act | Effective 01/01/2025